BREANA GALLAGHER: Open Payments
NPI 1417556408 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 41 payments from 14 companies in 2025. Trend: 2023 $1,301 · 2024 $1,052 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $113 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
| GENZYME CORPORATION | 3 | $65 |
| Incyte Corporation | 3 | $59 |
| PFIZER INC. | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| LEO Pharma Inc. | 2 | $34 |
Products named: DUPIXENT, RINVOQ, Sotyktu, COSENTYX, OPZELURA, ILUMYA, CIBINQO, TALTZ.
Industry payments across NY — which companies pay providers there.
